Acute decompensated heart failure
Acute pulmonary edema. Note enlarged heart size, apical vascular redistribution ( circle ), and small bilateral pleural effusions ( arrow ).
|Classification and external resources|
|eMedicine||med/3552 emerg/108 radio/189 med/1367150 ped/2636|
Acute decompensated heart failure (ADHF) is a worsening of the symptoms, typically shortness of breath (dyspnea), edema, and fatigue, in a patient with existing heart disease. ADHF is a common and potentially serious cause of acute respiratory distress. The condition is caused by severe congestion of multiple organs by fluid that is inadequately circulated by the failing heart. An attack of decompensation can be caused by underlying medical illness, such as myocardial infarction, infection, or thyroid disease.
Chronic stable heart failure may easily decompensate. This most commonly results from an intercurrent illness (such as pneumonia), myocardial infarction (a heart attack), arrhythmias, uncontrolled hypertension, or a patient's failure to maintain a fluid restriction, diet or medication. Other well recognised precipitating factors include anaemia and hyperthyroidism which place additional strain on the heart muscle. Excessive fluid or salt intake, and medication that causes fluid retention such as NSAIDs and thiazolidinediones, may also precipitate decompensation.
Acute myocardial infarction can precipitate acute decompensated heart failure and will necessitate emergent revascularization with thrombolytics, percutaneous coronary intervention, or coronary artery bypass graft.
In acute decompensated heart failure, the immediate goal is to re-establish adequate perfusion and oxygen delivery to end organs. This entails ensuring that airway, breathing, and circulation are adequate.
Initial therapy of acute decompensated heart failure usually includes some combination of a vasodilator such as nitroglycerin, a diuretic such as furosemide, and non-invasive positive pressure ventilation (NIPPV).
Even if symptoms of heart failure are not present, medications can be used to treat the symptoms that are being experienced. These medicines work to control these symptoms as well as treat other health problems that might be present. They can work to improve the quality of life, slow down the progression of heart failure and reduce the risk for other complications that can occur due to heart failure. It's very important to take proper medicines exactly as prescribed by the physician.
A number of different medications are required for people who are experiencing heart failure. Common types of medications that are prescribed for heart failure patients include ACE inhibitors, vasodilators, beta blockers, blood thinners, calcium channel blockers, and cholesterol lowering medications. Depending on the type of damage a patient has suffered and the underlying cause for the heart failure, any of these drug classes or a combination of them can be prescribed. Patients with heart pumping problems will use a different medication combination than those who are experiencing problems with the heart filling. Potentially dangerous drug interactions can occur when different drugs mix together and work against each other. All medications have side effects. Many over-the-counter medications will cause a condition of heart failure to worsen.
Nitrates such as nitroglycerine are often used as part of the initial therapy for ADHF.
Another option is nesiritide, although it should only be considered if conventional therapy has been ineffective or contraindicated as it is much more expensive than nitroglycerine and has not been shown to be of any greater benefit.
Heart failure is usually associated with a volume overloaded state. Therefore those with evidence of fluid overload should be treated initially with intravenous loop diuretics. In the absence of symptomatic hypotension intravenous nitroglycerin is often used in addition to diuretic therapy to improve congestive symptoms.
Volume status should still be adequately evaluated. Some heart failure patients on chronic diuretics can be over diuresed. In the case of diastolic dysfunction without systolic dysfunction, fluid resuscitation may in fact improve circulation by decreasing heart rate, which will allow the ventricles more time to fill. Even if the patient is edematous, fluid resuscitation may be the first line of treatment if the patient is hypotensive. The patient may in fact be intravascularly volume depleted, although if the hypotension is due to cardiogenic shock, additional fluid may make the situation worse. If the patient's circulatory volume is adequate but there is persistent evidence of inadequate end-organ perfusion, inotropes may be administered. In certain circumstances, a left ventricular assist device (LVAD) may be necessary.
Once the patient is stabilized, attention can be turned to treating pulmonary edema to improve oxygenation. Intravenous furosemide is generally the first line. However, patients on long-standing diuretic regimens can become tolerant, and dosages must be progressively increased. If high doses of furosemide are inadequate, boluses or continuous infusions of bumetanide may be preferred. These loop diuretics may be combined with thiazide diuretics such as oral metolazone or intravenous chlorthiazide for a synergistic effect. Intravenous preparations are physiologically preferred because of more predictable absorption due to intestinal edema, however, oral preparations can be significantly more cost effective.
- ACE inhibitors and ARBs
The effectiveness and safety of ACE inhibitor and angiotensin receptor blockers acutely in ADHF have not been well studied, but are potentially harmful. A person should be stabilized before therapy with either of these medication classes is initiated. Patients with poor renal perfusion are especially at risk for renal impairment inherent with these medications.
- Inotropic agents
Inotropes are indicated if hypotension ( BP < 90 ) is present.
Opiates have traditionally been used in the treatment of the acute pulmonary edema that results from acute decompensated heart failure. A 2006 review however found little evidence to support this practice.
Continuous positive airway pressure may be applied using a face mask; this has been shown to improve symptoms more quickly than oxygen therapy alone, and has been shown to reduce the risk of death. Severe respiratory failure requires treatment with endotracheal intubation and mechanical ventilation.
Certain scenarios will require emergent consultation with cardiothoracic surgery. Heart failure due to acute aortic regurgitation is a surgical emergency associated with high mortality. Heart failure may occur after rupture of ventricular aneurysm. These can form after myocardial infarction. If it ruptures on the free wall, it will cause cardiac tamponade. If it ruptures on the intraventricular septum, it can create a ventricular septal defect. Other causes of cardiac tamponade may also require surgical intervention, although emergent treatment at bedside may be adequate. It should also be determined whether the patient had a history of a repaired congenital heart disease as they often have complex cardiac anatomy with artificial grafts and shunts that may sustain damage, leading to acute decompensated heart failure.
In some cases, doctors recommend surgery to treat the underlying problem that led to heart failure. Different procedures are available depending on the level of necessity and include coronary artery bypass surgery, heart valve repair or replacement, or heart transplantation. During these procedures, devices such as heart pumps, pacemakers, or defibrillators might be implanted. The treatment of heart disease is rapidly changing and thus new therapies for acute heart failure treatment are being introduced to save more lives from these massive attacks.
Bypass surgery is performed by removing a vein from the arm or leg, or an artery from the chest and replacing the blocked artery in the heart. This allows the blood to flow more freely through the heart. Valve repair is where the valve that is causing heart failure is modified by removing excess valve tissues that cause them to close too tightly. In some cases, annuloplasty is required to replace the ring around the valves. If the repair of the valve isn't possible, it is replaced by an artificial heart valve. The final step is heart replacement. When severe heart failure is present and medicines or other heart procedures are not effective, the diseased heart needs to be replaced.
Another common procedure used to treat heart failure patients is an angioplasty. Is a procedure used to improve the symptoms of coronary artery disease (CAD), reduce the damage to the heart muscle after a heart attack, and reduce the risk of death in some patients. This procedure is performed by placing a balloon in the heart to open an artery that is blocked by atherosclerosis or a buildup of plaque on the artery walls. Patients who are experiencing heart failure because of CAD or recent heart attack, can benefit from this procedure.
A pacemaker is a small device that's placed in the chest or abdomen to help control abnormal heart rhythms. They work by sending electric pulses to the heart to prompt it to beat at a rate that is considered to be normal and are used to treat patients with arrhythmias. They can be used to treat hearts that are classified as either a tachycardia that beats too fast, or a bradycardia that beats too slow.
- Allen LA, O'Connor CM (13 March 2007). "Management of acute decompensated heart failure". CMAJ 176 (6): 797–805. doi:10.1503/cmaj.051620.
- Fonarow GC, Abraham WT, Albert NM et al. (April 2008). "Factors Identified as Precipitating Hospital Admissions for Heart Failure and Clinical Outcomes: Findings From OPTIMIZE-HF". Arch. Intern. Med. 168 (8): 847–854. doi:10.1001/archinte.168.8.847. PMID 18443260.
- Nieminen MS, Böhm M, Cowie MR et al. (February 2005). "Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology". Eur. Heart J. 26 (4): 384–416. doi:10.1093/eurheartj/ehi044. PMID 15681577.
- Torres M, Moayedi S (May 2007). "Evaluation of the acutely dyspneic elderly patient". Clin. Geriatr. Med. 23 (2): 307–25, vi. doi:10.1016/j.cger.2007.01.007. PMID 17462519.
- Heart Failure Society Of America (February 2006). "Evaluation and management of patients with acute decompensated heart failure". J. Card. Fail. 12 (1): e86–e103. doi:10.1016/j.cardfail.2005.11.017. PMID 16500576.
- Medications Commonly Used to Treat Heart Failure American Heart Association. Retrieved on 2010-01-22
- Lau, Brandyn D.; Pinto, Brian L.; Thiemann, David R.; Lehmann, Christoph U. (November 2011). "Budget Impact Analysis of Conversion from Intravenous to Oral Medication When Clinically Eligible for Oral Intake". Clinical Therapeutics 33 (11): 1792–1796. doi:10.1016/j.clinthera.2011.09.030.
- Gheorghiade M, Zannad F, Sopko G et al. (December 2005). "Acute heart failure syndromes: current state and framework for future research". Circulation 112 (25): 3958–68. doi:10.1161/CIRCULATIONAHA.105.590091. PMID 16365214.
- Valika, AA; Gheorghiade, M (Mar 2013). "Ace inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature.". Heart failure reviews 18 (2): 135–40. doi:10.1007/s10741-011-9295-6. PMID 22213014.
- Jondeau G, Neuder Y, Eicher JC et al. (September 2009). "B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode". Eur. Heart J. 30 (18): 2186–92. doi:10.1093/eurheartj/ehp323. PMID 19717851.
- "BestBets: Does the application of opiates, during an attack of Acute Cardiogenic Pulmonary Oedma, reduce patients' mortality and morbidity?". Retrieved December 6, 2008.
- Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J (July 2008). "Noninvasive ventilation in acute cardiogenic pulmonary edema". N. Engl. J. Med. 359 (2): 142–51. doi:10.1056/NEJMoa0707992. PMID 18614781.
- Peter JV, Moran JL, Phillips-Hughes J, Graham P, Bersten AD (April 2006). "Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis". Lancet 367 (9517): 1155–63. doi:10.1016/S0140-6736(06)68506-1. PMID 16616558.
- Weng CL, Zhao YT, Liu QH et al. (May 2010). "Meta-analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema". Ann. Intern. Med. 152 (9): 590–600. doi:10.1059/0003-4819-152-9-201005040-00009. PMID 20439577.
- Costanzo MR, Guglin ME, Saltzberg MT et al. (February 2007). "Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure". J. Am. Coll. Cardiol. 49 (6): 675–83. doi:10.1016/j.jacc.2006.07.073. PMID 17291932.
- Treatments and drugs for Heart Failure Mayo Clinic. Retrieved on 2010-01-22
- Acute Heart Failures Definition And Management Retrieved on 2010-01-22
- What Is Coronary Angioplasty National Heart Lung and Blood Institute. Retrieved on 2010-01-22
- What Is Coronary Angioplasty National Heart Lung and Blood Institute. Retrieved on 2010-01-22